27 Mar 2024


Trilegal advised Wockhardt Limited (“Wockhardt“) on its qualified institutions placement of equity shares aggregating to INR 4,800 million (“QIP“). Wockhardt is one of the key research-based pharmaceutical companies from India, and has a global footprint with operations spread across approximately 45 countries and 12 manufacturing facilities.
The proceeds from the QIP will be utilised towards repayment of borrowings and funding clinical trials and research and development of its novel antibiotics which are focused on resistant organisms.
DAM Capital Advisors Limited was the placement agent for the QIP. The QIP was anchored by marquee investors such as ICICI Prudential, Tata Indian Opportunities Fund, HDFC Mutual Fund and Societe Generale.
The Trilegal team was led by our Capital Markets Partner, Richa Choudhary, and comprised lawyers Avanti Kale, Counsel; Maitreya Rajurkar, Senior Associate; Sanya Chaudhari, Pooja Tada and Archit Jain, Associates.
Media link:
About Trilegal
Trilegal is one of India’s leading law firms, with expertise across the full spectrum of corporate legal services. Trilegal has offices in four key cities of India.
Trilegal has been recognised as the India Deal Firm of the Year by Asian Legal Business (ALB) India Law Awards 2023; one of the ‘Best Overall Law Firms’ at the India Business Law Journal Indian Law Firm Awards 2022; ‘Firm of the year’ for Client Service Excellence by Asia Law Awards 2021; “M&A Law firm of the Year” by VCCircle Awards 2020 one of the most innovative law firms in Asia in the inaugural edition of ALB Trailblazers 2020; and ‘highly commended’ in the FT RSG Innovative Lawyers Awards 2020.
For more information, please contact:
Sahil Wason
Mob: +91-8928008122 | BD@trilegal.com
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.